ALFA Finder| Revenue growth | 27.9% YoY in H1 FY27 |
|---|---|
| Margins | EBITDA margin 21.5% vs 22.0%; PAT margin 14.1% vs 15.0% |
| Demand visibility | Nutraceuticals and cosmetics growing; client retention 98% |
| Management confidence | Upbeat; reiterates 25% FY27 growth target |
Growth
Revenue +27.9%, EBITDA +25.1%, PAT +20.0%. Nutraceuticals ₹75.3cr (+25%); cosmetics roughly doubled to ₹6.9cr; ayurvedic fell 22%.
Outlook
FY27 growth target 25% with consistent margins. Palghar 75,000 sq ft plant to start commercial production in coming months; capacity to rise 2.5x.
Risks
EBITDA margin down 49bps and PAT margin down 93bps. Inventory days 124, cash conversion cycle 69 days, top-10 clients 50% of revenue.
Investor Presentation filed with NSE, NSE: INFLUX. Summary written with AI assistance from the document.
Influx Healthtech Ltd: key numbers
- Share price
- ₹251.00
- Market cap
- ₹581.1 Cr
- Revenue (annual)
- ₹146.8 Cr
- Net profit (annual)
- ₹20.54 Cr
- P/E (TTM)
- 28.3×Sector 43.0×
- Promoter holding
- 73.53%
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Influx Healthtech Ltd
All →Influx Healthtech Earnings Call Transcript: Key Takeaways
Revenue rose 27.9% to ₹85.4 Cr, but EBITDA and PAT margins both contracted, and capex of ₹19.9 Cr far exceeds ₹7.2 Cr operating cash flow.
- Call
- Guides 25% growth
Influx Healthtech H1 FY27 Results: Net Profit ₹12 Cr, Up 20.0% YoY
Influx Healthtech Ltd reported revenue from operations of ₹85.4 Cr (+27.8% YoY) and net profit of ₹12 Cr (+20.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹12 Cr · +20.0% YoY
Influx Healthtech Legal & Regulatory
NSE imposed a fine of Rs. 1.83 Lakhs on Influx Healthtech for a delay in submitting consolidated financial results for the half year ended March 31, 2026.
- Value
- ₹0.02 Cr
Influx Healthtech Annual General Meeting
Influx Healthtech Limited held its 6th Annual General Meeting on September 18, 2026. The company transacted the business items as per the AGM notice.
Influx Healthtech Other Announcement
Influx Healthtech dispatched letters to shareholders without registered emails with the FY 2025-26 Annual Report weblink and 6th AGM notice. The letters are sent under Regulation 36(1)(b) of the SEBI Listing Regulations.
Influx Healthtech Annual General Meeting
Influx Healthtech Ltd. has announced its 6th Annual General Meeting scheduled for September 18, 2026, and submitted its Annual Report for FY 2025-2026.